Study | Year | Modality | Complication rate (%) | Description |
---|---|---|---|---|
Forster and colleagues [25] | 2013 | VV (with CRRT) | Nil | Â |
Bein and colleagues [19] | 2013 | AV | 7.5 | 1× lower limb ischaemia, 2× aneurysm |
Nierhaus and colleagues [29] | 2011 | AV | 21.4 | 2× catheter displacement, 1× bleeding at insertion site |
Weber-Carstens and colleagues [26] | 2009 | AV | 6.3 | 1× transient occlusion of femoral artery during cannulation |
Zimmermann and colleagues [20] | 2009 | AV | 11.8 | 3× lower limb ischaemia, 1× cannula thrombosis, 1× bleeding during cannulation, 1× compartment syndrome |
Terragni and colleagues [21] | 2009 | VV | 25 | 1× pump malfunction, 3× membrane/haemofilter clotting, 1× catheter displacement, 3× cannula problems |
Muellenbach and colleagues [27] | 2008 | AV | 23 | 2× lower limb ischaemia, 1× femoral artery pseudoaneurysm, 1× lower limb amputation, 1× catheter displacement |
Bein and colleagues [28] | 2006 | AV | 24.4 | 9× lower limb ischaemia, 4× cannula thrombosis, 4× compartment syndrome, 2× aneurysm, 1× haemolysis, 1× intracerebral haemorrhage, 1× diffuse bleeding with shock on cannulation |
Liebold and colleagues [30] | 2002 | AV | 21 | 7× cannula thrombosis, 1× membrane clotting, 3× lower limb ischaemia, 5× membrane plasma leakage |
Guinard and colleagues [22] | 1997 | VV | NR | NR |
Morris and colleagues [18] | 1994 | VV | NR | 21× non-CNS haemorrhage (7 requiring discontinuation of ECCO2R), 4× circuit clotting |
Brunet and colleagues [23] | 1994 | VV | 18.2 | 1× alveolar haemorrhage, 1× diffuse bleeding |
Bindslev and colleagues [31] | 1991 | VV | NR | 1× allergic reaction |
Gattinoni and colleagues [24] | 1986 | VV | NR | 3× intra-pulmonary bleeding |